Comparing Intrathecal Morphine With Erector Spina Plane Block in Open Gastrectomy Surgery
Comparing Postoperative Analgesic Effects of Intrathecal Morphine With Erector Spina Plane Block in Open Gastrectomy Surgery
1 other identifier
observational
63
1 country
1
Brief Summary
Open gastrectomy causes severe postoperative pain due to wide surgical incisions, retraction of the abdominal wall and direct manipulation of the visceral organs. It leads to delayed postoperative recovery, increased medical expenses and poor surgical outcomes. Epidural analgesia, intrathecal morphine and patient-controlled analgesia are frequently used in the postoperative pain management of abdominal surgeries. Intrathecal morphine is applied as a standard protocol in many centers due to its ease of application and effective pain control. However; it has undesirable effects such as postoperative nausea-vomiting, itching and most importantly respiratory depression. Regional interfascial plane blocks, such as erector spina plane block, have recently been popular in clinical practice to provide postoperative pain control. Erector spina plane block, when placed preoperatively, is expected to reduce opioid consumption and improve outcomes. The primary implication of this study is to compare postoperative pain scores and opioid consumption. It is also aimed to compare the effectiveness of Numeric Rating Scale and Clinically Aligned Pain Assessment Tool used in postoperative pain assesment.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for all trials
Started Feb 2023
Shorter than P25 for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
January 4, 2023
CompletedFirst Posted
Study publicly available on registry
January 31, 2023
CompletedStudy Start
First participant enrolled
February 15, 2023
CompletedPrimary Completion
Last participant's last visit for primary outcome
February 1, 2024
CompletedStudy Completion
Last participant's last visit for all outcomes
February 1, 2024
CompletedMarch 28, 2024
March 1, 2024
12 months
January 4, 2023
March 27, 2024
Conditions
Keywords
Outcome Measures
Primary Outcomes (3)
Postoperative pain assessment with Numeric Rating Scale (NRS)
In a Numerical Rating Scale (NRS), patients are asked to choose the number between 0 and 10, that fits best to their pain intensity. Zero usually represents 'no pain at all' whereas ten represents 'the worst pain ever possible'
48 hours
Postoperative pain assessment with Clinically Aligned Pain Assessment (CAPA) Tool
CAPA tool functions as a conversation guide to gather categorical information during the course of a natural conversation. It focuses on how comfortable the patient is, whether discomfort is improving or worsening, whether the patient is able to participate in recovery activities and if pain is interfering with sleep.The clinician then codes and documents the conversation. Patient does not rate any scale or check boxes of responses.
48 hours
Comparison of postoperative opioid consumption between two groups via Patient Controlled Analgesia (PCA) device
Intravenous patient-controlled analgesia (PCA) is a system of opioid delivery that consists of an infusion pump interfaced with a timing device. Intravenous morphine consumption will be recorded via PCA device, then it will be documented in mg/kg units.
48 hours
Secondary Outcomes (2)
Comparison of the frequency of treatment related complications
48 hours
Participant satisfaction
48 hours
Study Arms (2)
Erector Spina Plane Block and Intravenous Patient Controlled Analgesia
Intrathecal Morphine and Intravenous Patient Controlled Analgesia
Interventions
Comparing postoperative pain and opioid consumption in groups
Eligibility Criteria
Patients over 18 years old undergoing open gastrectomy surgery in Marmara University Training and Research Hospital
You may qualify if:
- Patients over 18 years old
- Patients undergoing open gastrectomy surgery
You may not qualify if:
- Patients with solid organ dysfunction
- Patients who receive opioid or corticosteroid medication prior to surgery
- Patients with bleeding diathesis
- Patients with psychiatric disorders
- Patients who can not be contacted after surgery
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Marmara University School of Medicine
Istanbul, Turkey (Türkiye)
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Associate Professor
Study Record Dates
First Submitted
January 4, 2023
First Posted
January 31, 2023
Study Start
February 15, 2023
Primary Completion
February 1, 2024
Study Completion
February 1, 2024
Last Updated
March 28, 2024
Record last verified: 2024-03